Keyphrases
Lupus
85%
Systemic Lupus Erythematosus
78%
Systemic Lupus Erythematosus Patient
50%
Health-related Quality of Life
48%
Peruvian
46%
SLE Disease Activity Index (SLEDAI)
37%
Damage Accrual
30%
Disease Duration
24%
COVID-19
23%
Medical Students
23%
Disease Activity
22%
Damage Index
21%
Age at Diagnosis
21%
Remission
21%
Latin American
19%
Patient Data
17%
Visual Analog Scale
16%
Systemic Lupus International Collaborating Clinics
15%
Lupus Low Disease Activity State (LLDAS)
14%
Rheumatology
14%
COVID-19 Pandemic
14%
Disease Activity Score
14%
Multivariable
14%
Prednisone
11%
Rheumatic Diseases
11%
Homocysteine Levels
11%
Low Disease Activity State
11%
Living with
11%
Fear of Coronavirus
11%
Psychometric Properties
11%
Spanish Version
11%
Rapid Evaluation
11%
Clinician-reported Outcomes
11%
SLICC
11%
Emotional Health
11%
Single Center
10%
LupusQoL
10%
American College of Rheumatology
10%
Peru
9%
Numerical Rating Scale
9%
Physical Health
9%
Mental Health
8%
Mestizo
8%
Multivariable Model
8%
Activity State
7%
Fear of COVID-19 Scale (FCV-19S)
7%
Immunosuppressive Drugs
7%
Patient-Reported Outcomes Measurement Information System (PROMIS)
7%
Hospitalization
7%
Regression Analysis
6%
Medicine and Dentistry
Systemic Lupus Erythematosus
100%
Lupus Erythematosus
73%
Disease Activity
42%
Quality of Life
40%
SLEDAI
23%
Rheumatology
19%
Disease Duration
15%
Homocysteine
11%
Patient-Data
11%
COVID-19
11%
Visual Analog Scale
11%
Rheumatic Disease
9%
Prednisone
9%
Antimalarial Agent
9%
Disease
9%
Emotional Stability
8%
Numeric Rating Scale
7%
Immunosuppressive Drug
7%
Observational Study
6%
Glucocorticoid
6%
Clinician
6%
Disease Activity Score
5%
Meta-Regression
5%
Metabolic Syndrome
5%
Systematic Review
5%
Psychiatry
5%
Susac Syndrome
5%
Catatonia
5%
Uric Acid
5%
Self Concept
5%
Personal Experience
5%
Mental Health
5%
Rituximab
5%
Lupus Nephritis
5%
Frailty Index
5%